Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AMB-05X |
| Synonyms | |
| Therapy Description |
AMB-05X is a monoclonal antibody targeting CSF1R, which potentially decreases tumor growth (J Clin Oncol 41, no. 16_suppl (June 01, 2023) TPS11585). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AMB-05X | AMB05X|AMB 05X | CSF1R Antibody 5 | AMB-05X is a monoclonal antibody targeting CSF1R, which potentially decreases tumor growth (J Clin Oncol 41, no. 16_suppl (June 01, 2023) TPS11585). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05349643 | Phase II | AMB-05X | A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT | Completed | USA | NLD | AUS | 0 |
| NCT06617858 | Phase II | AMB-05X | Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment | Recruiting | USA | 0 |